Internal Server Error

About DNA Capital

DNA Capital is a venture capital firm founded in 2020. It is primarily based out of Hong Kong, China. It primarily invests in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Blockchain Technology. Overall, DNA Capital portfolio has seen 3 unicorns, 1 IPO and 4 acquisitions including key companies like Mysten Labs, Consensys and Applovin. DNA Capital has team of 2 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns

DNA Capital's List of Top Investments

DNA Capital has a portfolio of 18 companies, including 3 unicorns. Their most notable investments include Mysten Labs and Consensys.Their portfolio spans across United States, Canada, Cayman Islands and 4 more locations. They have invested in Enterprise Applications, High Tech, Blockchain Technology and 10 other sectors. Here is the list of top investments by DNA Capital:
Blockchain platform offering Web3 infrastructure solutions. Its product portfolio includes an open-source wallet packed with features to help developers access, learn, and transact on the Sui network, Sui Explorer for digging into metrics, searching for transactions, Sui name service to register identity, and more. It also offers digital collectibles called SuiFrens.

Key facts about Mysten Labs

Developer of blockchain and web3 software platform. Its product suite includes MetaMask, Infura, Linea, Truffle, Diligence, and an NFT platforms that supports users with building a dApp, an NFT collection, a portfolio, managing digital assets, and more.

Key facts about Consensys

Mobile marketing platform for attribution, targeting, and user acquisition. It provides a platform for marketers to track consumers across different mobile devices and automates the buying process. It delivers attribution, targeting, and user acquisition to brands, by providing personalized targeting and retargeting to users across apps. It combines known shopping behavior with data insights from customers interactions across screens smartphones, tablets, and computers.

Key facts about Applovin

  • Founded Year: 2012
  • Location: San Francisco (United States)
  • Annual Revenue: $1B+ as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $1.72B
  • Employee Count: 532 as on Sep 30, 2026
  • Investors: HTIF, De Anda Capital and 19 Others
  • Latest Funding Round: Series E, Aug 21, 2018, $*****
  • Highlight: Public
Provider of high performance computing platform for engineering and science. The platform offers solutions for simulation, data management, and workflow automation. It serves industries including aerospace, automotive, energy, and life sciences. The platform also provides resources for IT, engineering, and executive roles, with use cases in AI/ML, digital twin technology, and cloud solutions.

Key facts about Rescale

Provider of graph database management system and graph analytics platform. It offers graph database as a service and self-managed graph database deployment. The company provides graph analytics as a service and self-managed graph algorithms with machine learning modeling. It also offers tools for graph visualization, exploration, and database instance management.

Key facts about Neo4j

Unicorns in DNA Capital's Portfolio

DNA Capital has 3 unicorns in its portfolio - Mysten Labs, Consensys and Neo4j. The most recent unicorn in their portfolio is Mysten Labs. It became a unicorn in 2022, 4 years before DNA Capital first invested in it.
Here is a list of unicorns in DNA Capital's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
81
Blockchain platform offering Web3 infrastructure solutions
2021
Palo Alto
Series B
bqvzmkl
80
Developer of blockchain and web3 software platform
2014
Fort Worth
Series D
sdrobva
68
Provider of graph database management system and graph analytics platform
2007
San Mateo
Series F
vzqjpto

IPOs and Publicly Listed companies in DNA Capital's Portfolio

1 of DNA Capital's portfolio company became public -  Applovin. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2021 at marketcap of $28.6B
Here are DNA Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Apr 15, 2021
-
-
8995

Acquired companies in DNA Capital's Portfolio

4 companies from DNA Capital's portfolio have been acquired. The most recent acquisition was HyalRoute in May 2026 by Allied Gaming for $*****.
Here are DNA Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
May 25, 2026
-
-
8289
Oct 15, 2025
-
-
8051
Sep 03, 2025
-
-
6272
Jun 18, 2019
-
-
8329

Team profile of DNA Capital

DNA Capital has a team of 2 members located in China. DNA Capital's team does not sit on the board of any company as of now.

FAQs about DNA Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford